Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-920-1 | CAS number: 93280-40-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
skin irritation: negative
seious eye damage: positive
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Meets generally accepted scientific standards, well documented and acceptable for assessment.
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-5 (Acute Dermal Irritation)
- GLP compliance:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hazleton Research Animals Inc., Denver, Pennsylvania.
- Age at study initiation: young adults (at least 8 weeks old)
- Weight at study initiation: no data
- Housing: individually
- Diet: Lab Rabbit Chow HF (Purina #5326), 125 g/day while on test.
- Water: tap water, ad libitum.
- Acclimation period: 55 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 16 - 21 °C
- Humidity (%): 30 - 70 %
- Photoperiod (hrs dark / hrs light): 12 h / 12 h - Type of coverage:
- semiocclusive
- Preparation of test site:
- other: closely clipped
- Vehicle:
- physiological saline
- Controls:
- other: untreated skin of the same animals served as control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.5 grams per site; two intact sites per animal
- % coverage: at least 10 % of the body area
VEHICLE
- Amount(s) applied (volume or weight with unit): 0.25 ml - Duration of treatment / exposure:
- 4 h
- Observation period:
- 3 days
- Number of animals:
- 6 (2 males, 4 females).
- Details on study design:
- TEST SITE
- Type of wrap if used: gauze and porous tape
REMOVAL OF TEST SUBSTANCE
- Washing (if done): excess test material was removed using dry gauze.
- Time after start of exposure: 4 h
SCORING SYSTEM: draize score - Irritation parameter:
- erythema score
- Basis:
- mean
- Time point:
- other: 24 h - 48 - 72 h
- Score:
- 0.1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 72 h
- Irritation parameter:
- edema score
- Basis:
- mean
- Time point:
- other: 24 h - 48 h - 72 h
- Score:
- 0
- Max. score:
- 4
- Reversibility:
- other: no effects
Reference
Erythema findings: right front/left front:
Time | animal 1 | animal 2 | animal 3 | animal 4 | animal 5 | animal 6 |
0,5 h | 1/0 | 0/1 | 0/0 | 0/1 | 0/0 | 0/0 |
24 h | 0/1 | 0/0 | 0/0 | 0/1 | 0/0 | 0/0 |
48 h | 1/1 | 0/0 | 0/0 | 0/1 | 0/0 | 0/0 |
72 h | 0/0 | 0/0 | 0/0 | 0/0 | 0/0 | 0/0 |
Edema findings: right front/left front:
Time | animal 1 | animal 2 | animal 3 | animal 4 | animal 5 | animal 6 |
0,5 h | 0/0 | 0/0 | 0/0 | 0/0 | 0/0 | 0/0 |
24 h | 0/0 | 0/0 | 0/0 | 0/0 | 0/0 | 0/0 |
48 h | 0/0 | 0/0 | 0/0 | 0/0 | 0/0 | 0/0 |
72 h | 0/0 | 0/0 | 0/0 | 0/0 | 0/0 | 0/0 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Meets generally accepted scientific standards, well documented and acceptable for assessment.
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-4 (Acute Eye Irritation)
- GLP compliance:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: Hazleton-Dutchland Inc., Denver, Pennsylvania.
- Age at study initiation: young adults (at least 8 weeks old)
- Weight at study initiation: no data
- Housing: individually
- Diet: Lab Rabbit Chow HF (Purina #5326), 125 g/day while on test.
- Water: tap water, ad libitum.
- Acclimation period: 56 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 16 - 21 °C
- Humidity (%): 30 - 70 %
- Photoperiod (hrs dark / hrs light): 12 h / 12 h - Vehicle:
- unchanged (no vehicle)
- Controls:
- other: the adjacent eye served as control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 1 cm3 - Duration of treatment / exposure:
- Single application
- Observation period (in vivo):
- max. 28 days
- Number of animals or in vitro replicates:
- 6 (3 males and 3 females)
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing (if done): Approximately 24 h after application, the treated eyes were rinsed to remove any residual test application.
SCORING SYSTEM: draize score, with the following deviations:
Cornea:
Opaclity - degree of density
No opacIty = 0
SIight dulling of normal luster = +
Scattered or difuse areas of opacity (other than slight dulling of normal luster). details of iris clearly visible . = 1*
Easily discerniole transluscent areas; details of iris slightly obscured = 2*
Nacrous area. no detalles of iris visible, size of pupil barely discernible = 3*
Opaque cornea, iris not discernisle through opacity = 4*
Iris
Normal = 0
Slight deepening of the rugae or slight hyperemia of the circumcorneal blood vessels = +
Markedly deepened folds (above normal). congestion, swelling, moderate circumcorneal hyperemia or injection (any or all of these or combination of thereof), iris still reacting to light (sluggish reaction is positive} = 1*
No reaction to light, hemorrhage, gross destruction (any or all of these} = 2*
"*" = Score considered positive;
"+" = Not included in SPA grading system, values assigned if finding present.
TOOL USED TO ASSESS SCORE: fluorescein - Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Time point:
- other: 24 h - 48 h - 72 h
- Score:
- 1.3
- Max. score:
- 4
- Reversibility:
- not fully reversible within: 28 days in 3 of 6 animals
- Irritation parameter:
- iris score
- Basis:
- mean
- Time point:
- other: 24 h - 48 h - 72 h
- Score:
- 1.1
- Max. score:
- 2
- Reversibility:
- fully reversible within: 28 days
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Time point:
- other: 24 h - 48 h - 72 h
- Score:
- 2.7
- Max. score:
- 3
- Reversibility:
- not fully reversible within: 28 days in 3 of 6 animals
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Time point:
- other: 24 h - 48 h - 72 h
- Score:
- 2.4
- Max. score:
- 4
- Reversibility:
- not fully reversible within: 28 days in 2 of 6 animals
- Other effects:
- The test substance caused serious damage to eyes. All six animals exhibited severe conjunctival irritation (redness, chemosis, discharge, necrosis), corneal opacity, ulceration and iridial damage. All six animals also exhibited pannus (vascularized connective tissue like excrescence) one or more times between days 7 and 28. On day 7 one animal had an enlarged blood vessel on the anterior surface of the iris. Two animals had a fluid filled blister on the corneal surface on day 21 and/or 28. Three animals were noted to have hair loss around the eye. All six animals continued to exhibit severe irritation at termination of the study (day 28).
Reference
Findings animals 1/2/3/4/5/6 (undiluted test substance):
Time | Opacity | Iritis | Conjunctival Erythema | Conjunctival Chemosis | |
1 h | +/+/+/0/+/+ | +/0/+/+/0/+ | 2/1/1/1/1/1 | 0/0/0/0/0/1 | |
24 h | 2/1/2/2/2/2 | 1/1/1/1/1/1 | 3/3/3/3/3/3 | 3/3/3/3/3/3 | |
48 h | 2/+/2/1/2/2 |
2/1/1/1/1/1 | 3/3/3/2/2/3 | 3/2/3/2/2/2 | |
72 h | 2/+/1/+/+/+ | 2/1/1/1/+/1 | 3/2/3/2/2/2 | 2/2/2/2/2/2 | |
7 d | 4/+/1/2/+/1 | 2/1/1/1/0/+ | 2/2/2/2/1/2 | 1/1/2/1/1/1 | |
14 d | 2/+/2/1/0/0 | 2/1/1/0/0/0 | 2/2/2/2/2/1 | 2/1/1/1/0/0 | |
21 d | +/+/1/1/0/0 | 1/0/0/0/0/0 | 1/1/1/1/1/1 | 1/0/0/1/0/0 | |
28 d | 2/+/2/2/0/0 | 0/0/0/0/0/0 | 1/1/0/1/0/0 | 1/0/0/1/0/0 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irreversible damage)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Additional information
There are no substance specific information on Vanadate(1-), oxo[phosphato(3-)-κO]-, hydrogen, hydrate (2:2:1) for skin, eye and respiratory irritaion available. However, data from other vanadium compounds were taken into account to access the respective endpoint.
Skin Irritation:
A study was conducted to evaluate the dermal irritation produced by E-326 Catalyst (Divanadyl pyrophosphate, CAS 65232 -89-5) in rabbits when administered for a 4-hour interval under a semi-occlusive covering (BASF, 1989). E-326 Catalyst produced mild and transient dermal irritation. The only irritation seen was very slight (barely perceptible) erythema in three of the six animals which subsided within one to three days. The Average Dermal Irritation Score of E-326 Catalyst is 0.1.
Eye Irritation:
The study was conducted to evaluate the ocular irritation produced by E-326 Catalyst (Divanadyl pyrophosphate, CAS 65232 -89-5) in rabbits. E-326 Catalyst was corrosive to the eye. All six animals exhibited severe conjunctival irritation (redness, chemosis, discharge, necrosis), corneal opacity and ulceration and iridial damage. All six animals also exhibited pannus (neovascularization of the corneal surface) one or more times between Days 7 and 28. On Day 7, one animal had an enlarged blood vessel on the anterior surface of the iris. Two animals had a fluid filled blister on the corneal surface on Day 21 and/or 28. Three animals were noted to have hair loss around the eye. All six animals exhibited residual test material in the eye at 1 and 24 hours. All six animals continued to exhibit severe irritation at termination of the study (Day 28).
Respiratory Irritation:
There are several epidemiological studies linking upper respiratory symptoms to vanadium pentoxide exposure (Kiviluoto, 1980; Kiviluoto et al., 1979a; Lewis, 1959, Zenz and Berg, 1967 Zenz et al. 1962). Effects were observed even after single exposure (e.g. Zenz & Berg, 1967). Long-term chronic exposure data of workers in the vanadium industry are reported in several publications by Kiviluoto et al. In a factory manufacturing vanadium pentaoxide, 63 workers exposed toV2O5 at concentrations of 0.1 to 3.9 mg V/m3 measured as total dust for 11 years (average 0.2-0.5 mg V/m3) did not have an increased prevalence of upper respiratory symptoms in the case study by Kiviluoto et al (1979a,b, 1980, 1981a,b). However, other epidemiological data support that respiratory symptoms are observed at exposure concentrations of V2O5 that are above 0.1 mg/ V/m3.
According to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008, Annex VI, V2O5 is classified with STOT SE 3.
Justification for classification or non-classification
Currently there is no substance specific data on Vanadate(1-), oxo[phosphato(3-)-κO]-, hydrogen, hydrate (2:2:1) for skin irritation / corrosion and eye irritation available. However data from the source compound Divanadyl pyrophosphate (CAS 65232-89-5) as well as the pentavalent vanadium compound Divanadium pentoxide (CAS 1314-62-1) can be taken into account for hazard assessment.
Based on the available data and according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008
Vanadate(1-), oxo[phosphato(3-)-κO]-, hydrogen, hydrate (2:2:1) has to be classified as Eye Damage 1 (H318) and STOT SE 3 (H335). No classification for skin irritation is warrented.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.